Core Insights - The first photon-counting spectral CT, uCTUltima, developed by United Imaging Healthcare, has received approval from the National Medical Products Administration (NMPA) for commercialization in China, marking a significant breakthrough in medical technology [1][2] - United Imaging Healthcare is the first Chinese company to successfully commercialize photon-counting spectral CT globally, overcoming high technical barriers that previously limited this technology to two foreign companies [1][2] Group 1 - The photon-counting spectral CT technology offers advantages over traditional CT, including higher spatial resolution imaging, direct multi-energy spectrum imaging, and lower radiation dose imaging, significantly advancing precision diagnosis and treatment [1][2] - The company has collaborated with several institutions, including Zhongshan Hospital and Ruijin Hospital, to leverage their strengths in machine development, clinical application, and testing for the photon-counting spectral CT project [2] - Innovations in detector design have reduced pixel area to one-ninth of traditional CT, allowing for the visualization of finer pathological structures while maintaining image quality through advanced correction and reconstruction algorithms [2] Group 2 - The photon-counting spectral CT can reduce radiation doses by 60% to 70%, and in some organs, reductions can reach 80% to 90%, enhancing patient safety during CT scans [2] - The technology has already been implemented in clinical research at Fudan University Zhongshan Hospital and Shanghai Jiao Tong University School of Medicine Ruijin Hospital [3]